Renaissance Technologies’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.9M Buy
+790,937
New +$34.6M 0.06% 409
2024
Q2
Sell
-10,190
Closed -$309K 3893
2024
Q1
$309K Buy
+10,190
New +$300K ﹤0.01% 3080
2023
Q4
Sell
-483,200
Closed -$13.1M 4066
2023
Q3
$13.1M Sell
483,200
-287,500
-37% -$8.54M 0.02% 766
2023
Q2
$23.7M Sell
770,700
-530,200
-41% -$18M 0.03% 599
2023
Q1
$46.9M Buy
1,300,900
+431,900
+50% +$16M 0.06% 369
2022
Q4
$34.3M Buy
+869,000
New +$36.3M 0.05% 470
2022
Q2
Sell
-183,900
Closed -$7.17M 4517
2022
Q1
$7.17M Sell
183,900
-615,200
-77% -$24.2M 0.01% 1348
2021
Q4
$31.8M Buy
799,100
+15,500
+2% +$602K 0.04% 484
2021
Q3
$28.3M Sell
783,600
-45,000
-5% -$1.75M 0.04% 521
2021
Q2
$34M Buy
+828,600
New +$35.2M 0.04% 487

Other funds holding RPRX